A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.
Eur Heart J
; 36(31): 2070-2078, 2015 Aug 14.
Article
en En
| MEDLINE
| ID: mdl-25990342
Buscar en Google
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Idioma:
En
Año:
2015
Tipo del documento:
Article